CAS: 2070015-14-2
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Atovaquone-d4 REF: 4Z-A-271CAS: | - - - | To inquire | Tue 07 Jan 25 |
 | Atovaquone-d4 REF: TM-T19198CAS: 2070015-14-2 | 98% | To inquire | Thu 09 Jan 25 |
 | Atovaquone-d4 REF: 3D-VHD01514CAS: 2070015-14-2 | Min. 95% | To inquire | Tue 18 Feb 25 |
Ref: 4Z-A-271
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Tuesday 7 Jan 2025
Atovaquone-d4
CAS:2070015-14-2
Atovaquone D4 is a deuterium-labeled drug for treating malaria, pneumonia, and toxoplasmosis.
Formula:
C22H19ClO3
Purity:
98%
Color and Shape:
Solid
Molecular weight:
370.86
Ref: TM-T19198
| 1mg | 369.00 € | ||
| 5mg | 1,129.00 € | ||
| 10mg | 1,843.00 € | ||
| 25mg | 3,479.00 € |
Estimated delivery in United States, on Thursday 9 Jan 2025
Atovaquone-d4
CAS:2070015-14-2
Atovaquone-d4 is an analog of atovaquone, a medication used to treat and prevent malaria. It …
Formula:
C22H19ClO3
Purity:
Min. 95%
Molecular weight:
370.9 g/mol
Ref: 3D-VHD01514
| 1mg | To inquire | ||
| 5mg | To inquire | ||
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Tuesday 18 Feb 2025
